NDC 70771-1087-2 - oxybutynin
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 70771-1087
- Requested NDC
- 70771-1087-2
- Package NDCs from labels
- 70771-1087-6, 70771-1087-1, 70771-1087-9, 70771-1087-5, 70771-1087-3, 70771-1087-2, 70771-1087-4
- Manufacturer
- Zydus Lifesciences Limited
- Effective date
- 2024-12-03
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| oxybutynin - Zydus Lifesciences Limited | Zydus Lifesciences Limited | 2024-12-03 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 70771-1087-1 | oxybutynin | 100 in 1 BOTTLE | TABLET, FILM COATED, EXTENDED RE | 100 | 8 | |
| 70771-1087-2 | oxybutynin | 10 in 1 BLISTER PACK | TABLET, FILM COATED, EXTENDED RE | 10 | 8 | |
| 70771-1087-3 | oxybutynin | 30 in 1 BOTTLE | TABLET, FILM COATED, EXTENDED RE | 30 | 8 | |
| 70771-1087-4 | oxybutynin | 10 in 1 CARTON | TABLET, FILM COATED, EXTENDED RE | 10 | 8 | |
| 70771-1087-5 | oxybutynin | 500 in 1 BOTTLE | TABLET, FILM COATED, EXTENDED RE | 500 | 8 | |
| 70771-1087-6 | oxybutynin | 60 in 1 BOTTLE | TABLET, FILM COATED, EXTENDED RE | 60 | 8 | |
| 70771-1087-9 | oxybutynin | 90 in 1 BOTTLE | TABLET, FILM COATED, EXTENDED RE | 90 | 8 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 70771-1087 | OXYBUTYNIN TABLET, FILM COATED, EXTENDED RELEASE [ZYDUS LIFESCIENCES LIMITED] | 8 | Current NDC, Legacy NDC, 7 package rows | 20241206_f405a774-bd91-4513-b7c7-c44f0596d988.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Clear Eyes Triple Relief | POLYVINYL ALCOHOL AND POVIDONE AND TETRAHYDROZOLINE HYDROCHLORIDE | Prestige Brands Holdings, Inc. | 1269a1a6-843d-4d08-bb3c-c1f3d2e7080d | 2024-10-25 | Warnings | FZ989GH94E |
| Oxybutynin Chloride | OXYBUTYNIN CHLORIDE | Aphena Pharma Solutions - Tennessee, LLC | 2425f49f-ade3-5178-e063-6294a90adfac | 2024-10-10 | Warnings, Adverse reactions | L9F3D9RENQ |
| Oxybutynin Chloride | OXYBUTYNIN CHLORIDE | Bryant Ranch Prepack | 246d2f79-8ab5-4023-9068-1451b695ac16 | 2024-10-03 | Warnings, Adverse reactions | L9F3D9RENQ |
| Advanced Eye Relief/ Redness Maximum Relief | NAPHAZOLINE HYDROCHLORIDE AND HYPROMELLOSE | Bausch & Lomb Incorporated | 3c11285a-7e86-4b47-b1ee-e7d59858087d | 2024-09-25 | Warnings | 3NXW29V3WO |
| oxybutynin | OXYBUTYNIN | NCS HealthCare of KY, LLC dba Vangard Labs | ec4fd95f-16dc-4acf-b560-b67b7aaef08b | 2024-09-13 | Warnings, Adverse reactions | ANDA202332 863619 L9F3D9RENQ |
| Oxybutynin Chloride | OXYBUTYNIN CHLORIDE | Teva Pharmaceuticals USA, Inc. | cb7aba8d-6913-4f57-8eb4-c6d6ff0b2a29 | 2024-09-02 | Warnings, Adverse reactions | L9F3D9RENQ |
| Oxybutynin Chloride | OXYBUTYNIN CHLORIDE | NuCare Pharmaceuticals,Inc. | 8e830697-a6d3-13ed-e053-2995a90acb11 | 2024-08-14 | Warnings, Adverse reactions | L9F3D9RENQ |
| oxybutynin | OXYBUTYNIN | NCS HealthCare of KY, LLC dba Vangard Labs | ed10f0c9-23d6-4ded-b17f-ed474632a965 | 2024-08-12 | Warnings, Adverse reactions | ANDA202332 863636 L9F3D9RENQ |
| OXYBUTYNIN CHLORIDE | OXYBUTYNIN CHLORIDE | Bryant Ranch Prepack | f26e590d-956e-493b-a6ac-6056aeeaf411 | 2024-08-09 | Warnings, Adverse reactions | L9F3D9RENQ |
| OXYBUTYNIN CHLORIDE | OXYBUTYNIN CHLORIDE | RISING PHARMA HOLDINGS, INC. | f8ed80f2-6c3d-4d7f-b761-c2447973c1f9 | 2024-07-03 | Warnings, Adverse reactions | L9F3D9RENQ |
| Artificial Tears | POLYVINYL ALCOHOL, POVIDONE | NuCare Pharmaceuticals,Inc. | 9c1c4911-908e-3c3c-e053-2995a90abcfc | 2024-06-14 | Warnings | FZ989GH94E |
| oxybutynin chloride | OXYBUTYNIN CHLORIDE | A-S Medication Solutions | 7593becc-250f-4d25-8401-a9f72f3f5ad4 | 2024-06-03 | Warnings, Adverse reactions | 863636 L9F3D9RENQ |
| oxybutynin chloride | OXYBUTYNIN CHLORIDE | A-S Medication Solutions | 8f147f73-cfc6-40a3-b1a3-e4cab1868523 | 2024-06-03 | Warnings, Adverse reactions | 863619 L9F3D9RENQ |
| Oxybutynin Chloride | OXYBUTYNIN CHLORIDE | A-S Medication Solutions | 39a2d144-0c10-4aec-9fa4-0adc24b332eb | 2024-06-03 | Warnings, Adverse reactions | L9F3D9RENQ |
| Oxybutynin Chloride Extended Release | OXYBUTYNIN CHLORIDE | Bryant Ranch Prepack | 169d6d58-8887-4bdd-95bd-873d1f049eaa | 2024-05-24 | Warnings, Adverse reactions | 863619 L9F3D9RENQ |
| Oxybutynin Chloride Extended Release | OXYBUTYNIN CHLORIDE | Proficient Rx LP | 7d2332b4-9e48-4bb2-a2c3-75e16e1d455b | 2024-04-01 | Warnings, Adverse reactions | 863619 L9F3D9RENQ |
| Clear Eyes Natural Tears | POLYVINYL ALCOHOL AND POVIDONE | Prestige Brands Holdings, Inc. | efba3eb0-798d-4635-b19b-4970e45b3cc9 | 2024-04-01 | Warnings | FZ989GH94E |
| REFRESH CLASSIC | POLYVINYL ALCOHOL, POVIDONE | A-S Medication Solutions | 3bf6193c-56db-45ad-844c-58eb8c33cba9 | 2024-03-14 | Warnings | FZ989GH94E |
| GOODSENSE ARTIFICIAL TEARS | POLYVINYL ALCOHOL | Proficient Rx LP | f29c792c-6cb2-449f-b97d-6304a58dec2a | 2024-02-01 | Warnings | FZ989GH94E |
| GoodSense Artifical Tears | POLYVINYL ALCOHOL, AND POVIDONE | Proficient Rx LP | cd24da78-fd90-4a9c-8e5f-f7fc56ec0fc9 | 2024-02-01 | Warnings | FZ989GH94E |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.